General MedicationsTOPICALStandard
CLODERM
CLOCORTOLONE PIVALATE
Standard Dose
0.1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview CLODERM is listed in Drugs@FDA under application 017765 (NDA).
Review priority: N/A Marketing status: Prescription Active ingredient CLOCORTOLONE PIVALATE Form and strength CREAM;TOPICAL - 0.1% Sponsor LEGACY PHARMA Submission history Latest submission status date: 2009-05-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLODERM is listed in Drugs@FDA under application 017765 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient CLOCORTOLONE PIVALATE Form and strength CREAM;TOPICAL - 0.1% Sponsor LEGACY PHARMA Submission history Latest submission status date: 2009-05-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.